# A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India

> **NCT06370715** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 150 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Lispro-aabc
- **DRUG:** Insulin Glargine

## Key facts

- **NCT ID:** NCT06370715
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-18
- **Primary completion:** 2025-09-02
- **Final completion:** 2025-09-02
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2025-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06370715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06370715, "A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06370715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*